09:59
+9 C°
Traffic jam:   6
$
56.9690
58.8705
Healthcare

Healthcare

Walmart Health Introduces Telehealth Diabetes Program To Help Businesses Support Employees Through Education and Behavioral Care
28 April 2022
1687
BENTONVILLE, Ark. April 28, 2022 — More than 37 million Americans have been diagnosed with diabetes, and its prevalence is expected to grow 54% by 2030. According to the National Institutes of Health (NIH), fewer than 20% of people with di
Orthofix Announces New Business Unit President
8 April 2022
1686
LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced a leadership transition for its Orthopedics Business Unit. Kimberley Elting, currently Chief
Incyte Announces 52-Week Data From the Phase 3 TRuE-V Program Evaluating Ruxolitinib Cream (Opzelura™) in Patients With Vitiligo
26 March 2022
1701
WILMINGTON, Del.--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) today announced new 52-week results from its pivotal Phase 3 TRuE-V clinical trial program evaluating ruxolitinib cream (Opzelura™), a topical JAK1/JAK2 inhibitor, in adolescent and adult
Johnson & Johnson Consumer Health Unveils New Skin Health Research at 2022 American Academy of Dermatology Meeting
25 March 2022
1748
SKILLMAN, N.J., March 25, 2022 – Johnson & Johnson Consumer Inc. will present new research highlighting important advances in the understanding and treatment of skin at the 2022 American Academy of Dermatology (AAD) Meeting, taking pla
Pfizer Announces Positive Top-Line Results for Phase 3 Trial of Etrasimod in Ulcerative Colitis Patients
23 March 2022
1714
NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) today announced positive topline results from a Phase 3 study of etrasimod, an investigational, oral, once-a-day, selective sphingosine 1-phosphate (S1P) receptor modulator in development for the tr
Catalent, Inc. to Present at the KeyBanc Life Sciences & MedTech Investor Forum
18 March 2022
1728
Catalent, the global leader in enabling biopharma, cell, gene, and consumer health partners to optimize development, launch, and supply of better patient treatments across multiple modalities, today announced that members of its executive leadership
Moderna and Thermo Fisher Scientific Announce Long-Term Strategic Collaboration
23 February 2022
1784
Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced a 15-year strategic collaboration agre
European Medicines Agency Approves Pfizer’s 20-Valent Pneumococcal Conjugate Vaccine Against Invasive Pneumococcal Disease and Pneumonia in Adults
15 February 2022
1818
Pfizer Inc. (NYSE:PFE) today announced that the European Medicines Agency (EMA) has approved the company’s 20-valent pneumococcal conjugate vaccine (PCV20), which will be marketed in the European Union (EU) under the brand name APEXXNAR. The va
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2021
4 February 2022
1780
Bristol Myers Squibb (NYSE:BMY) today reports results for the fourth quarter and full year of 2021, which reflect strong sales driven by robust commercial execution and significant advancement of the company’s pipeline that further progres
Pfizer and Ionis Announce Discontinuation of Vupanorsen Clinical Development Program
31 January 2022
1782
Pfizer Inc. (NYSE: PFE) and Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) today announced the discontinuation of the Pfizer-led clinical development program for vupanorsen (PF-07285557), an investigational antisense therapy that was being
Pfizer Shares In Vitro Efficacy of Novel COVID-19 Oral Treatment Against Omicron Variant
18 January 2022
1800
Pfizer Inc. (NYSE: PFE) today shared results from multiple studies demonstrating that the in vitro efficacy of nirmatrelvir, the active main protease (Mpro) inhibitor of PAXLOVID™ (nirmatrelvir [PF-07321332] tablets and ritonavir
Johnson & Johnson COVID-19 Vaccine Demonstrates 85 Percent Effectiveness against Hospitalization in South Africa when Omicron was Dominant
30 December 2022
1762
Johnson & Johnson (NYSE: JNJ) (the Company) today announced new preliminary results from the South African Phase 3b Sisonke study which showed that a homologous (same vaccine) booster shot of the Johnson & Johnson COVID-19 vaccine (Ad26.COV2.
Dicerna Announces Expiration of Hart-Scott-Rodino Act Waiting Period for Novo Nordisk Tender Offer to Acquire Dicerna
25 December 2021
1710
Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA) today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (“HSR”), in connection with Novo Nordisk’s cash tender offer for Di
Omeros Completes Sale of OMIDRIA Franchise to Rayner Surgical
23 December 2021
1787
Omeros Corporation (Nasdaq: OMER) today announced that it has completed the sale of OMIDRIA (phenylephrine and ketorolac intraocular solution) 1.0%/0.3% to Rayner Surgical Group Inc., an affiliate of Rayner Surgical Group Limited. The transaction was
Moderna announces preliminary booster data and updates strategy to address Omicron variant
20 December 2021
1825
Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced preliminary neutralizing antibody data against the Omicron variant following the Company’s booster candidates at 50
BeyondSpring pharmaceuticals announces new clinical data confirming plinabulin's fast onset mechanism of action in the prevention of  chemotherapy-induced neutropenia at the 63RD ash annual meeting and exposition
17 December 2021
1754
Beyond Spring Pharmaceuticals (the “Company” or “BeyondSpring”) (NASDAQ: BYSI), a global pharmaceutical company focused on the development of cancer therapeutics, today announced new data highlighting the mechanism of action o
New Clinical and Real-World Data Support Use of DARZALEX® (daratumumab) in Patients with Newly Diagnosed Multiple Myeloma
11 December 2021
1775
The Janssen Pharmaceutical Companies of Johnson & Johnson announced today new analyses illustrating responses that first-line treatment with DARZALEX® (daratumumab)-based regimens may be able to achieve, including a potential survival be
UnitedHealthcare Introduces Health Plan Delivering Lower Costs and a Patient-Focused Health Care Experience
2 December 2021
1814
UnitedHealthcare has introduced a new health plan that offers consumers in Southwest Arizona personalized and seamless customer support as well as the opportunity to save up to 15% on premiums. The Doctors Plan of Arizona provides access to quality,
Johnson & Johnson Discussions to License its COVID-19 Vaccine to Aspen Reach Advanced Stage
30 November 2021
1843
Johnson & Johnson is pleased to reach an advanced stage in its discussions for a potential licensing agreement for its COVID-19 vaccine with Aspen SA Operations (Pty) Ltd, which is based in South Africa. The parties will continue to work toward a
Cardinal Health Teams Up with Zipline for Automated, On-Demand Delivery to Retail Pharmacies
17 November 2021
1836
Cardinal Health (NYSE: CAH) and Zipline, the global leader in instant logistics, today announced a collaboration to offer on-demand autonomous aircraft delivery to pharmacies. Cardinal Health will use Zipline’s service for on-demand r
  • 1
  • 2

NEW YORK PRESS RELEASES


GlobalNY.biz Press Releases are the latest news from New York companies.
Official press releases of New York companies are regularly published on the resource. You can find out the latest news of enterprises in the corresponding section on the main page. Placing press releases is a traditional and effective way to promote your business. It allows organizations to announce themselves and their products and services to the widest possible audience. In this case, the informational occasion can be anything: attracting people to an event or conference, highlighting new products or personnel appointments. If you set a goal to draw attention to your information, then GlobalNY.biz will become your reliable assistant in this matter. Thanks to the portal, your press release will be seen by reviewers of leading Internet publications, clients and partners.
GlobalNY.biz allows representatives of companies and organizations in New York to independently post a press release when registering on the resource. The most important feature of GlobalNY.biz is that all publications of New York companies fall into the archives and will be available from the search for a long time. You just need to add the press release to the news feed.
GlobalNY.biz offers its customers a subscription service that allows companies to regularly publish press releases on favorable terms. In addition, the business portal makes it possible to more fully tell about the life of the company by adding photos and videos, personas and employee quotes. All information materials have active links and will lead potential customers to your resource.
Alena Potapova

Development Director
Population
7952685313
Died this year
23499367
Born this year
57812602